Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.

The deal meaningfully expands Waters’ exposure to biologics, diagnostics, and regulated laboratory workflows while adding a ...

According to MarketsandMarkets™, the Cell Culture Reagents Market is projected to grow from about USD 5.06 billion in 2025 to ...

Beam Therapeutics jumps 22% after outlining 2026 pipeline goals, including accelerated approval plans for BEAM-302 and a ...

Vermont Business Magazine Prolytix, a Vermont-based leader in bioanalytical and protein characterization services, announces it has acquired 60 validated assays previously owned by Hemostasis ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

For India, the future is likely a hybrid ecosystem: robust central laboratory analyzers complemented by decentralised, rapid-response coagulation devices. Sysmex is well positioned to operate across ...

Using robots and click chemistry, scientists built potential active ingredients for future antibiotics that contain metal.

Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...

Cytek expects its total revenue for the full year 2025 to be approximately $201 million. Expected revenue for the fourth quarter of 2025 of approximately $62 million represents growth of 8% compared ...

According to MarketsandMarkets, the Cell Culture Reagents Market is projected to grow from about USD 5.06 billion in 2025 to USD 8.95 billion ...